EUVIMEDEUVIMED entdecken
Klinische Studie

Topical Silymarin Cream as a Novel Therapy Versus Salicylic Acid Peels in Acne Vulgaris: A Split-Face Clinical Trial

Dalia Abdel-Aziz Atallah, Aya Yousef Badran, Alaa Gamal Makhlouf, Marwa Mohammad Mekkawy iD

Journal of Cutaneous Medicine and Surgery · 2024-01 · 28 (1) · 22-28

DOI: 10.1177/12034754231211568 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Journal of Cutaneous Medicine and Surgery, online erschienen am 09.11.2023. Verfasst von Dalia Abdel-Aziz Atallah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Assiut University, Assiut, Egypt. Hauptthemen laut MEDLINE: Acne Vulgaris, Salicylic Acid, Silymarin. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acne vulgaris is a common dermatological condition that greatly impacts patients’ self-confidence. Ongoing research is conducted to explore new treatment modalities. Silymarin owns special characteristics that qualify it as a possible treatment for acne vulgaris.

Objective

We evaluated the efficacy and safety of silymarin cream as a new therapeutic option against salicylic acid peels in the treatment of mild to moderate acne vulgaris.

Methods

A split-face, comparative, Quasi-experimental clinical trial included 30 patients with acne vulgaris. Salicylic acid 30% peels were applied as an office procedure to one half of the face every 2 weeks for 3 months. Topical silymarin 1.4% cream was prescribed as a home treatment, twice daily, to the other half of the face for 3 months. The results were evaluated using the Global Acne Grading System (GAGS), photographic evaluation, and patient self-assessment scale. The adverse effects during treatment were recorded. The sample size was calculated by Stata/IC 16.1.

Results

After treatment, a significant reduction of GAGS was noted on both sides of the face, with an insignificant difference between both treatments. The comparative photographic evaluation and patient self-assessment scale were also insignificant. Hyperpigmentation was recorded in 2 cases on the salicylic acid-treated side. No side effects for silymarin cream were observed.

Conclusion

Topical silymarin cream 1.4% showed comparable results to Salicylic acid 30% peels. It can be considered a promising safe treatment modality for mild to moderate acne vulgaris.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acne VulgarisSalicylic AcidSilymarinHumansEmollientsHyperpigmentation

Stichwörter der Autor:innen

acne vulgarischemical peelsnew therapysalicylic acid peeltopical silymarin

Substanzen

EmollientsSalicylic AcidSilymarin

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Assiut University, Assiut, Egypt.

ORCID-Profile: Marwa Mohammad Mekkawy

Zitieren

APA

Atallah, D. A., Badran, A. Y., Makhlouf, A. G., & Mekkawy, M. M. (2024). Topical Silymarin Cream as a Novel Therapy Versus Salicylic Acid Peels in Acne Vulgaris: A Split-Face Clinical Trial. Journal of Cutaneous Medicine and Surgery, 28(1), 22-28. https://doi.org/10.1177/12034754231211568

Vancouver

Atallah DA, Badran AY, Makhlouf AG, Mekkawy MM. Topical Silymarin Cream as a Novel Therapy Versus Salicylic Acid Peels in Acne Vulgaris: A Split-Face Clinical Trial. Journal of Cutaneous Medicine and Surgery. 2024;28(1):22-28. doi:10.1177/12034754231211568

BibTeX
@article{Atallah2024,
  author = {Atallah, Dalia Abdel-Aziz and Badran, Aya Yousef and Makhlouf, Alaa Gamal and Mekkawy, Marwa Mohammad},
  title = {Topical Silymarin Cream as a Novel Therapy Versus Salicylic Acid Peels in Acne Vulgaris: A Split-Face Clinical Trial},
  journal = {Journal of Cutaneous Medicine and Surgery},
  year = {2024},
  volume = {28},
  number = {1},
  pages = {22--28},
  doi = {10.1177/12034754231211568}
}
Kostenlos starten →